First-in-Human trial aims to offer new hope for patients with leaky heart valves who Can't have surgery
Disease control
Recruiting now
This early study tests a new device called the Capstan System, which replaces the mitral valve without open-heart surgery. It is for people with severe mitral regurgitation (a leaky heart valve) who are too sick for traditional surgery. The trial will check if the device can be s…
Phase: NA • Sponsor: Capstan Medical • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC